Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Toxicoproteomics: first experiences in a BMBF-study].

Michaela Kröger1, Jürgen Hellmann, Luca Toldo

  • 1Institut für Toxikologie, Merck KGaA, D-Darmstadt. michaela.kroeger@merck.com

ALTEX
|April 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why CEOs need advanced education and training for optimizing decisions in the development of innovative medicinal products? justification and recommendation.

Frontiers in pharmacology·2025
Same author

L-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies.

Journal of pharmacological and toxicological methods·2021
Same author

l-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies.

Journal of pharmacological and toxicological methods·2021
Same author

Digital transformation in healthcare - architectures of present and future information technologies.

Clinical chemistry and laboratory medicine·2018
Same author

Knowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis Ontology.

PloS one·2015
Same author

Manufactured nanomaterials: categorization and approaches to hazard assessment.

Archives of toxicology·2014
Same journal

New approach methodologies as first tier in an integrated approach to testing and assessment for non-genotoxic carcinogens.

ALTEX·2026
Same journal

Assessing the FDA's Year One Progress Report on Reducing Animal Testing.

ALTEX·2026
Same journal

Europe's roadmap finally arrives: Long on rigor, short on a clock.

ALTEX·2026
Same journal

Towards advanced in vitro models of testicular steroidogenesis for endocrine disruption testing.

ALTEX·2026
Same journal

Evaluation of EndoSens: A reliable skin sensitization assessment model.

ALTEX·2026
Same journal

Serum-free in vitro assessment of receptor-mediated endocrine activity including Phase-1 metabolism.

ALTEX·2026
See all related articles

Proteomic analysis using 2DE/MS and SELDI can identify early biomarkers for toxic and carcinogenic effects in the liver. This molecular toxicology approach promises improved risk assessment and reduced animal testing in chemical safety evaluations.

Area of Science:

  • Molecular toxicology
  • Proteomics
  • Biomarker discovery

Context:

  • The Rat Liver Foci Bioassay (RLFB) is a standard model for studying chemical-induced liver carcinogenesis.
  • Early detection of toxic and carcinogenic properties of substances is crucial for risk assessment.
  • Proteomic techniques like 2DE/MS and SELDI offer novel approaches to molecular toxicology.

Purpose:

  • To investigate the utility of proteomic methods for early recognition of toxic and carcinogenic characteristics of chemical substances.
  • To identify and prevalidate novel hepatocellular biomarkers for predicting toxic and carcinogenic effects.
  • To enhance the meaningfulness of the RLFB and improve chemical risk assessment.

Summary:

  • Proteomic analysis using two-dimensional gel electrophoresis/mass spectrometry (2DE/MS) and surface-enhanced laser desorption/ionization (SELDI) was applied to rat liver tissues.

Related Experiment Videos

  • Differentially expressed proteins related to metabolic pathways and carcinogenesis were identified, with changes detectable shortly after exposure.
  • Bioinformatics analysis of SELDI spectra identified specific mass peaks indicative of tumor formation, correlating with histopathological endpoints.

    • Impact:

    • This study demonstrates the potential of proteomic biomarkers for predicting hepatotoxicity and carcinogenicity.
    • The findings could lead to a more efficient RLFB, reducing the time and number of animals required for carcinogenicity studies.
    • Improved prediction of chemical toxicity through protein markers enhances overall chemical safety and risk assessment strategies.